Global
Contact Us
DKSH Japan participated in the “JAIMA Summer Science School 2026”, engaging students in a hands-on nanoparticle measurement workshop using advanced nanoparticle tracking analysis technology. The initiative highlighted the role of science and technology in addressing societal challenges and reflects DKSH’s commitment to empowering future scientists through STEM education.
DKSH expands its prescription drug portfolio in South Korea through an agreement with Novartis. DKSH will provide access for hypertension treatments Diovan® and Exforge® in the region.
DKSH has signed an agreement to acquire the Meliane oral contraceptive brand from Bayer across 30 markets in Europe, North Africa, Asia, and the Middle East. The acquisition is in line with DKSH’s strategy to expand its Healthcare Own Brands portfolio and strengthen its presence in higher-value segments and services.
DKSH has entered into an exclusive distribution agreement with Galaxy Surfactants, a leading manufacturer of specialty ingredients for the home and personal care industry, across Benelux, DACH, the Nordics and Baltics, and the United Kingdom. Leveraging its strong distribution network, technical capabilities, and service offering, DKSH will enhance growth opportunities for this strategic partnership across these key European markets.
DKSH has entered into an exclusive distribution agreement with Brilliant Group, a leading manufacturer of high-quality daylight fluorescent pigments, in Austria, Belgium, Germany, Luxembourg, the Netherlands, and Switzerland. Through this partnership, DKSH will increase access to Brilliant Group’s specialty pigment portfolio, helping customers develop innovative products across a broad range of industrial applications.
DKSH Singapore extends its partnership with Universal Robina Corporation. Through the expanded collaboration DKSH strengthens the market presence of Jack ’n Jill Potato Chips and Roller Coaster chips, bringing beloved snack favorites to more consumers across Singapore.
Corrigendum to the ad hoc announcement of 17 July 2026: EPS in H1 2026 was CHF 1.56 (not CHF 1.67), representing growth of 10.6% compared to H1 2025 (not 18.2%). The full text of the corrected announcement is as follows: Net sales of CHF 5.5 billion (+4.9% at CER1) Core EBIT of CHF 163.4 million (+3.6% at CER) Core EBIT margin of 3.0% Increase of Earnings per share (EPS) by 10.6% to CHF 1.56 Free Cash Flow of CHF 147.7 million (130.8% cash conversion rate) Three acquisitions announced in H1 2026 and good pipeline for H2 Stronger H2 expected: improving commercial momentum, data center project pipeline and M&A potential Mid-term roadmap confirmed
Net sales of CHF 5.5 billion (+4.9% at CER1) Core EBIT of CHF 163.4 million (+3.6% at CER) Core EBIT margin of 3.0% Increase of Earnings per share (EPS) by 18.2% to CHF 1.67 Free Cash Flow of CHF 147.7 million (130.8% cash conversion rate) Three acquisitions announced in H1 2026 and good pipeline for H2 Stronger H2 expected: improving commercial momentum, data center project pipeline and M&A potential Mid-term roadmap confirmed
DKSH receives two awards for its e-commerce initiatives in Malaysia and Singapore at the “Retail Asia Awards 2026”. This double recognition highlights DKSH’s integrated approach to helping consumer brands navigate an increasingly complex digital commerce landscape across the region.
Reach out to our Group Media Relations team for any inquiries.
Manager, Group Media Relations
Contact us to discover new opportunities.